GlobalData’s report assesses the drugs in the Activin Receptor Like Kinase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
The prospective trial aims to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ARO-INHBE.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-INHBE, the company’s investigational RNA ...